Inventor · disambiguated record
Mark R. Kelley
Also filed as: KELLEY III MARK R · KELLEY MARK · KELLEY MARK R
20 granted patents·15 pending applications·136 citations·filing 1989–2023
95Inventor score
Files withUNIV INDIANA RES & TECH CORP22ADVANCED RES & TECH INST5KELLEY MARK R5INDIANA UNIV AND RES TECH CORP1INDIANA UNIVERSITY AND RES TECHNOLOGY CORP1
Top patents by PatentIndex Score
35 records- 0194US11648226B2Use of APE1/Ref-1 inhibitors for treatment of retinal diseasesUNIV INDIANA RES & TECH CORP·Filed 2020·Granted May 16, 2023·4 cites·6 claims
- 0291US11331294B2Benzoquinone derivative E3330 in combination with chemotherapeutic agents for the treatment of bladder cancerUNIV INDIANA RES & TECH CORP·Filed 2019·Granted May 17, 2022·4 cites·7 claims
- 0388US11723886B2Targeting ocular diseases with novel APE1/Ref-1 inhibitorsUNIV INDIANA RES & TECH CORP·Filed 2019·Granted Aug 15, 2023·3 cites·9 claims
- 0487US6252048B1DNA sequences encoding fusions of DNA repair proteins and uses thereofADVANCED RES & TECH INST·Filed 2000·Granted Jun 26, 2001·18 cites·11 claims
- 0586US11351130B2Prevention and reversal of inflammation induced DNA damageUNIV INDIANA RES & TECH CORP·Filed 2020·Granted Jun 7, 2022·3 cites·14 claims
- 0686US9040505B2Benzoquinone derivative E3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesisKELLEY MARK R·Filed 2008·Granted May 26, 2015·6 cites·12 claims
- 0785US10154973B2Quinone compounds for treating APE1 mediated diseasesUNIV INDIANA RES & TECH CORP·Filed 2018·Granted Dec 18, 2018·3 cites·19 claims
- 0881US12350247B2Use of APE1/Ref-1 inhibitors for treatment of retinal diseasesUNIV INDIANA RES & TECH CORP·Filed 2023·Granted Jul 8, 2025·0 cites·7 claims
- 0980US9877936B2Quinone compounds for treating Ape1 mediated diseasesUNIV INDIANA RES & TECH CORP·Filed 2015·Granted Jan 30, 2018·2 cites·20 claims
- 1079US9193700B2Quinone compounds for treating Ape1 mediated diseasesKELLEY MARK R·Filed 2012·Granted Nov 24, 2015·3 cites·7 claims
- 1179US2022184016A1Benzoquinone derivative e3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesisUNIV INDIANA RES & TECH CORP·Filed 2022·Application pending·0 cites
- 1278US9089605B2Quinone derivatives, pharmaceutical compositions, and uses thereofKELLEY MARK R·Filed 2008·Granted Jul 28, 2015·4 cites·2 claims
- 1377US11160770B2Compounds, compositions and methods for treating oxidative DNA damage disordersUNIV INDIANA RES & TECH CORP·Filed 2020·Granted Nov 2, 2021·1 cites·19 claims
- 1477US9315481B2Compounds and methods for treating leukemiaUNIV INDIANA RES & TECH CORP·Filed 2013·Granted Apr 19, 2016·3 cites·5 claims
- 1575US10772859B2Methods of targeting APE/Ref-1 to inhibit hypoxia signaling genesUNIV INDIANA RES & TECH CORP·Filed 2016·Granted Sep 15, 2020·1 cites·3 claims
- 1674US10058523B2Benzoquinone derivative E3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesisUNIV INDIANA RES & TECH CORP·Filed 2015·Granted Aug 28, 2018·1 cites·9 claims
- 1773US6406917B1Methods and compositions for the use of apurinic/apyrimidinic endonucleasesADVANCED RES & TECH INST·Filed 2000·Granted Jun 18, 2002·10 cites·3 claims
- 1871US2023330046A1Targeting ocular diseases with novel ape1/ref-1 inhibitorsUNIV INDIANA RES & TECH CORP·Filed 2023·Application pending·0 cites
- 1969US6046036ADNA sequences encoding fusions of DNA repair proteins and uses thereofADVANCED RES & TECH INST·Filed 1997·Granted Apr 4, 2000·22 cites·19 claims
- 2067US2019231728A1Benzoquinone derivative e3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesisUNIV INDIANA RES & TECH CORP·Filed 2019·Application pending·0 cites
- 2166US5919643AMethods and compositions for the use of apurinic/apyrimidinic endonucleasesADVANCED RES & TECH INST·Filed 1997·Granted Jul 6, 1999·26 cites·15 claims
- 2266US2019365671A1Compounds, compositions and methods for treating oxidative dna damage disordersUNIV INDIANA RES & TECH CORP·Filed 2019·Application pending·0 cites
- 2365US2018325853A1Benzoquinone derivative e3330 in combination with chemotherapeutic agents for the treatment of colon cancerUNIV INDIANA RES & TECH CORP·Filed 2018·Application pending·0 cites
- 2462US2019160034A1Use of ape1/ref-1 inhibitors in combination therapies for treatment of cancerUNIV INDIANA RES & TECH CORP·Filed 2018·Application pending·0 cites
- 2560US2022249421A1Benzoquinone derivatives for the treatment of bladder cancerUNIV INDIANA RES & TECH CORP·Filed 2022·Application pending·0 cites
- 2656US2014128398A1Compounds, compositions and methods for treating oxidative dna damage disordersKELLEY MARK R·Filed 2012·Application pending·0 cites
- 2755US6190661B1Methods and compositions for the use of apurinic/apyrimidinic endonucleasesADVANCED RES & TECH INST·Filed 1999·Granted Feb 20, 2001·17 cites·12 claims
- 2855US2022062205A1Treatment of gastrointestinal disorders and symptoms thereofUNIV INDIANA RES & TECH CORP·Filed 2019·Application pending·0 cites
- 2954US2016166521A1Compounds, Compositions and Methods for Treating Oxidative DNA Damage DisordersINDIANA UNIVERSITY AND RES TECHNOLOGY CORP·Filed 2016·Application pending·0 cites
- 3051US2017304222A1Compounds, Compositions and Methods for Treating Oxidative DNA Damage DisordersINDIANA UNIV AND RES TECH CORP·Filed 2017·Application pending·0 cites
- 3151US2019117602A1Prevention and reversal of inflammation induced dna damageUNIV INDIANA RES & TECH CORP·Filed 2018·Application pending·0 cites
- 3249US2024216315A1Methods and compositions for treatment of diabetic retinopathy and related conditionsOCUPHIRE PHARMA INC·Filed 2022·Application pending·0 cites
- 3346US2019365689A1Use of ape/ref-1 redox specific inhibitors for treating metastatic prostate cancerUNIV INDIANA RES & TECH CORP·Filed 2018·Application pending·0 cites
- 3433US2019350885A1Prophylaxis treatment for acute myeloid leukemiaUNIV INDIANA RES & TECH CORP·Filed 2018·Application pending·0 cites
- 3521US4911586APlug for pier holeKELLEY MARK R·Filed 1989·Granted Mar 27, 1990·5 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Mark R. Kelley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →